Legal Representation
Attorney
Shannon Smith
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-19)
Due Date
March 19, 2025
Grace Period Ends
September 19, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 eventsDate | Code | Type | Description |
---|---|---|---|
May 24, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
May 24, 2025 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
May 24, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Feb 3, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
Mar 19, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Mar 19, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jan 1, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jan 1, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Dec 12, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Nov 29, 2018 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Nov 29, 2018 | ALIE | A | ASSIGNED TO LIE |
Nov 7, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Nov 6, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Nov 5, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Nov 5, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jun 28, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jun 28, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jun 28, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jun 26, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 21, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Mar 19, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Business consulting services in the fields of mergers and acquisitions, business contracts, intellectual property risk mitigation, investments in intellectual property and intangible business assets, intellectual property valuations, intellectual property fund development and management, financial investments and financial valuations, financial asset management, fundraising, product development, and clinical trials and FDA compliance
First Use Anywhere:
Apr 14, 2014
First Use in Commerce:
Apr 14, 2014
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"VENTURE MANAGEMENT"